[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.89.187. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 8, 1968

Salivary Secretion of Blood Factors in Cancer

Author Affiliations

Salt Lake City

JAMA. 1968;205(2):115. doi:10.1001/jama.1968.03140280069024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:—  This is a response to a paper entitled "Salivary Secretion of Blood-Group Factors in Cancer" by Krant et al (204:153, 1968).Dr. Krant has made rather Sweeping conclusions on inadequate material. Examination of Table 1, under column "lung," shows a rather startling skew in the number of sese (nonsecretory) patients listed as group O. Serologists and immunologists are aware of errors in H (O) secretion recognition with Ulex europaeus. Lea cell typing should be done to confirm the sese status. Since he shows a 34% sese here I would suspect mistyping of secretion because if no significance existed we would expect 22.7%. Under groups A, B, and AB, this does not show because they could check the secretor status with anti A or B or both to make a confirmation.Dr. Krant does not list a category of "survivors" so it is difficult to interpret

×